Cargando…

Mammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis

BACKGROUND AND PURPOSE: We aimed to determine 1) the frequency of mammillary body (MB) atrophy in patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS), 2) the clinical significance of MB atrophy, and 3) the association between MB atrophy and volume changes in other subcortical l...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Kyoo Ho, Lee, Ho-Joon, Lee, Dong Ah, Park, Kang Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669561/
https://www.ncbi.nlm.nih.gov/pubmed/36367061
http://dx.doi.org/10.3988/jcn.2022.18.6.635
_version_ 1784832126794858496
author Cho, Kyoo Ho
Lee, Ho-Joon
Lee, Dong Ah
Park, Kang Min
author_facet Cho, Kyoo Ho
Lee, Ho-Joon
Lee, Dong Ah
Park, Kang Min
author_sort Cho, Kyoo Ho
collection PubMed
description BACKGROUND AND PURPOSE: We aimed to determine 1) the frequency of mammillary body (MB) atrophy in patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS), 2) the clinical significance of MB atrophy, and 3) the association between MB atrophy and volume changes in other subcortical limbic structures. METHODS: We enrolled 69 patients with pathologically confirmed TLE with HS, who underwent a standard anterior temporal lobectomy, as well as 40 healthy controls. We used the FreeSurfer deep-learning tool of U-Net to obtain the volumes of the subcortical limbic structures, including the MB, hypothalamus, basal forebrain, septal nuclei, fornix, and nucleus accumbens. MB atrophy was considered to be present when the MB volume was decreased relative to the healthy controls. RESULTS: MB atrophy was present in 18 (26.1%) of the 69 patients with TLE and HS. Among the clinical characteristics, the mean age at seizure onset was higher (25.5 vs. 15.9 years, p=0.027) and the median duration of epilepsy was shorter (149 vs. 295 months, p=0.003) in patients with than without MB atrophy. The basal forebrain (0.0185% vs. 0.0221%, p=0.004) and septal nuclei (0.0062% vs. 0.0075%, p=0.003) in the ipsilateral hemisphere of HS were smaller in the patients with MB atrophy. CONCLUSIONS: We observed ipsilateral MB atrophy in about one-quarter of patients with TLE and HS. The severity of subcortical limbic structure abnormalities was greater in patients without MB atrophy. These findings suggest that MB atrophy in TLE with HS is not rare, but it has little clinical significance.
format Online
Article
Text
id pubmed-9669561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Neurological Association
record_format MEDLINE/PubMed
spelling pubmed-96695612022-11-29 Mammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis Cho, Kyoo Ho Lee, Ho-Joon Lee, Dong Ah Park, Kang Min J Clin Neurol Original Article BACKGROUND AND PURPOSE: We aimed to determine 1) the frequency of mammillary body (MB) atrophy in patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS), 2) the clinical significance of MB atrophy, and 3) the association between MB atrophy and volume changes in other subcortical limbic structures. METHODS: We enrolled 69 patients with pathologically confirmed TLE with HS, who underwent a standard anterior temporal lobectomy, as well as 40 healthy controls. We used the FreeSurfer deep-learning tool of U-Net to obtain the volumes of the subcortical limbic structures, including the MB, hypothalamus, basal forebrain, septal nuclei, fornix, and nucleus accumbens. MB atrophy was considered to be present when the MB volume was decreased relative to the healthy controls. RESULTS: MB atrophy was present in 18 (26.1%) of the 69 patients with TLE and HS. Among the clinical characteristics, the mean age at seizure onset was higher (25.5 vs. 15.9 years, p=0.027) and the median duration of epilepsy was shorter (149 vs. 295 months, p=0.003) in patients with than without MB atrophy. The basal forebrain (0.0185% vs. 0.0221%, p=0.004) and septal nuclei (0.0062% vs. 0.0075%, p=0.003) in the ipsilateral hemisphere of HS were smaller in the patients with MB atrophy. CONCLUSIONS: We observed ipsilateral MB atrophy in about one-quarter of patients with TLE and HS. The severity of subcortical limbic structure abnormalities was greater in patients without MB atrophy. These findings suggest that MB atrophy in TLE with HS is not rare, but it has little clinical significance. Korean Neurological Association 2022-11 2022-09-23 /pmc/articles/PMC9669561/ /pubmed/36367061 http://dx.doi.org/10.3988/jcn.2022.18.6.635 Text en Copyright © 2022 Korean Neurological Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Cho, Kyoo Ho
Lee, Ho-Joon
Lee, Dong Ah
Park, Kang Min
Mammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis
title Mammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis
title_full Mammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis
title_fullStr Mammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis
title_full_unstemmed Mammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis
title_short Mammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis
title_sort mammillary body atrophy in temporal lobe epilepsy with hippocampal sclerosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669561/
https://www.ncbi.nlm.nih.gov/pubmed/36367061
http://dx.doi.org/10.3988/jcn.2022.18.6.635
work_keys_str_mv AT chokyooho mammillarybodyatrophyintemporallobeepilepsywithhippocampalsclerosis
AT leehojoon mammillarybodyatrophyintemporallobeepilepsywithhippocampalsclerosis
AT leedongah mammillarybodyatrophyintemporallobeepilepsywithhippocampalsclerosis
AT parkkangmin mammillarybodyatrophyintemporallobeepilepsywithhippocampalsclerosis